Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1985 Sep 1;162(3):864–876. doi: 10.1084/jem.162.3.864

Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha)

PMCID: PMC2187816  PMID: 3839840

Abstract

The effects of long-term administration of very large doses of Sn- protoporphyrin on hematological indices, histological changes, plasma bilirubin levels, tissue heme oxygenase activity, and activities of heme biosynthetic enzymes, were examined in genetically anemic mutant mice with hemolytic anemia (sphha/sphha). Long-term weekly treatment with Sn-protoporphyrin (100 mumol/kg body weight for 32 wk) did not alter hematological indices, histological findings, or enzyme activities related to heme biosynthesis, even though it resulted in sustained decreases in microsomal heme oxygenase activity in the liver, kidney, and spleen, and a prolonged decrease in plasma bilirubin concentration. Inhibition of heme oxygenase did not alter the level of cytochrome P-450 in the liver and the kidney. The results indicate that long-term treatment with massive doses of Sn-protoporphyrin suppresses bilirubin formation but does not produce significant histopathological changes or appreciably interfere with heme synthesis, in this strain of genetically anemic mice. These findings provide further support for the idea that suppression of heme degradation to bile pigment by the inhibition of heme oxygenase may prove useful to the prevention of severe hyperbilirubinemia in humans.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. E., Simionatto C. S., Drummond G. S., Kappas A. Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase. J Pharmacol Exp Ther. 1984 Feb;228(2):327–333. [PubMed] [Google Scholar]
  2. Bernstein S. E. Inherited hemolytic disease in mice: a review and update. Lab Anim Sci. 1980 Apr;30(2 Pt 1):197–205. [PubMed] [Google Scholar]
  3. Drummond G. S., Kappas A. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest. 1984 Jul;74(1):142–149. doi: 10.1172/JCI111394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Drummond G. S., Kappas A. Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model. Science. 1982 Sep 24;217(4566):1250–1252. doi: 10.1126/science.6896768. [DOI] [PubMed] [Google Scholar]
  5. Drummond G. S., Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6466–6470. doi: 10.1073/pnas.78.10.6466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kappas A., Drummond G. S. Control of heme and cytochrome P-450 metabolism by inorganic metals, organometals and synthetic metalloporphyrins. Environ Health Perspect. 1984 Aug;57:301–306. doi: 10.1289/ehp.8457301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kappas A., Drummond G. S., Sardana M. K. Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver. J Clin Invest. 1985 Jan;75(1):302–305. doi: 10.1172/JCI111689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kappas A., Drummond G. S., Simionatto C. S., Anderson K. E. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin. Hepatology. 1984 Mar-Apr;4(2):336–341. doi: 10.1002/hep.1840040227. [DOI] [PubMed] [Google Scholar]
  9. Kappas A., Simionatto C. S., Drummond G. S., Sassa S., Anderson K. E. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci U S A. 1985 Feb;82(3):896–900. doi: 10.1073/pnas.82.3.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kreimer-Birnbaum M., Bannerman R. M., Russell E. S., Bernstein S. E. Pyrrole pigments in normal and congenitally anaemic mice (+:+, W-W v , ha-ha, nb-nb, mk-mk, f-f and sla-Y). Comp Biochem Physiol A Comp Physiol. 1972 Sep 1;43(1):21–30. doi: 10.1016/0300-9629(72)90464-1. [DOI] [PubMed] [Google Scholar]
  11. Milleville G. S., Levitt M. D., Engel R. R. Tin protoporphyrin inhibits carbon monoxide production in adult mice. Pediatr Res. 1985 Jan;19(1):94–96. doi: 10.1203/00006450-198501000-00025. [DOI] [PubMed] [Google Scholar]
  12. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  13. Roth M. Dosage fluorimétrique de la bilirubine. Clin Chim Acta. 1967 Sep;17(3):487–492. doi: 10.1016/0009-8981(67)90225-2. [DOI] [PubMed] [Google Scholar]
  14. Sassa S., Bernstein S. E. Levels of delta-aminolevulinate dehydratase, uroporphyrinogen-I synthase, and protoporphyrin IX in erythrocytes from anemic mutant mice. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1181–1184. doi: 10.1073/pnas.74.3.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sassa S., Drummond G. S., Bernstein S. E., Kappas A. Tin-protoporphyrin suppression of hyperbilirubinemia in mutant mice with severe hemolytic anemia. Blood. 1983 May;61(5):1011–1013. [PubMed] [Google Scholar]
  16. Sassa S., Kappas A., Bernstein S. E., Alvares A. P. Heme biosynthesis and drug metabolism in mice with hereditary hemolytic anemia. Heme oxygenase induction as an adaptive response for maintaining cytochrome P-450 in chronic hemolysis. J Biol Chem. 1979 Feb 10;254(3):729–735. [PubMed] [Google Scholar]
  17. Simionatto C. S., Anderson K. E., Drummond G. S., Kappas A. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production. J Clin Invest. 1985 Feb;75(2):513–521. doi: 10.1172/JCI111727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Simionatto C. S., Anderson K. E., Sassa S., Drummond G. S., Kappas A. Fluorometric measurement of tin-protoporphyrin in biological samples. Anal Biochem. 1984 Aug 15;141(1):213–219. doi: 10.1016/0003-2697(84)90448-2. [DOI] [PubMed] [Google Scholar]
  19. Trotman B. W., Bernstein S. E., Bove K. E., Wirt G. D. Studies on the pathogenesis of pigment gallstones in hemolytic anemia: description and characteristics of a mouse model. J Clin Invest. 1980 Jun;65(6):1301–1308. doi: 10.1172/JCI109793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yoshinaga T., Sassa S., Kappas A. Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation. J Biol Chem. 1982 Jul 10;257(13):7778–7785. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES